Due to the Corona vaccine, Moderna is suing Biontech and Pfizer | DW Arabic news | Breaking news and perspectives from around the world | DW

Release Moderna Laboratory Friday (August 26, 2022) a court battle against Pfizer and Piontech, accusing them of infringing patents on core technologies for a messenger RNA vaccine against Covid-19.

“Moderna is convinced that the Kommernati vaccine from Pfizer and Biontech against COVID-19 infringes on the patents that Moderna filed between 2010 and 2016,” said a statement from the company. Moderna has indicated that it intends to use its messenger RNA technology to develop treatments for influenza, human immunodeficiency virus (HIV), autoimmune diseases, cardiovascular disease and cancers.

A revolution in the world of vaccines

Moderna and Pfizer (a collaborator with Biontech) were the first to start, shortly after the outbreak the pandemicBy producing vaccines against the Corona virus with messenger RNA technology that enables human cells to generate proteins present in the virus so that the immune system gets used to recognizing and suppressing this virus.

Before that, vaccines were based on viral doses whose effect was weakened or nullified, allowing the body to get used to dealing with the virus. The development of treatments that required clinical trials to verify their safety often took several years.

The use of messenger RNA technology in the world’s most widely used Moderna and Pfizer/Biontech vaccines is the culmination of four decades of research that has overcome many obstacles. Great hopes are placed on this technology, which offers wide flexibility and the ability to stimulate the production of antigens in the body.

Moderna said it filed suit in the US state of Massachusetts and in the US state of DusseldorfGermany.

The resolution of this legal dispute may take several years.

Pfizer/Biontech revealed in a letter to AFP that it had not yet seen the full content of the complaint. However, the two groups did not hide their surprise at these developments, as the Pfizer/Biontech vaccine against Covid-19 “is based on the exclusive messenger RNA technology of Biontech and was developed in the framework of a collaboration between Piontech and Pfizer.” Both groups expressed their willingness to “viciously” defend their interests against Moderna’s claims.

Pursuing Moderna itself

This is not the first patent infringement lawsuit launched over the new mRNA technology. The Moderna Group is being pursued by two small biotech companies, Arbutus Biopharma Corporation and Genevent Sciences. Biontech is a complaint filed in Germany by the German company CureVac, to which Pfizer/Biontech responded with a lawsuit in the United States.

“We are launching these prosecutions to protect our innovative messenger RNA technology platform, which we have invested billions of dollars in and patented in the decade leading up to the COVID-19 pandemic,” said Stefan Bancel, director general of Moderna Laboratories. said in the statement. .

Moderna explained that since October 2020 it has committed not to bring prosecutions related to intellectual property as long as the pandemic is raging, but believes that the situation has changed. The company is not asking for the Pfizer/Biontech vaccine to be withdrawn from the market, but instead is asking for financial compensation for the vaccines that have only been sold since March.

Pfizer expects to generate $32 billion from Sales of its COVID-19 vaccine From the beginning of 2022 to its end.

Moderna explained that the patents that are the subject of prosecution against Pfizer and Biontech were not developed when it was working with the US research agency to accelerate work to limit the spread of COVID-19.

CS/AS (AFP, DPA)

Leave a Comment